What Researchers Did
Researchers investigated the U.S. Air Force experience with ground level oxygenation as a primary treatment for Type 1 altitude chamber decompression sickness between 1989 and 1991.
What They Found
Out of 221 cases of Type 1 decompression sickness, 175 were initially treated with ground level oxygen. Of these, 135 cases (77%) resolved completely with ground level oxygen, avoiding the need for hyperbaric oxygen therapy. Only 8 patients experienced symptom recurrence after resolution with ground level oxygen, all of which subsequently resolved with compression therapy.
What This Means for Canadian Patients
This study suggests that ground level oxygen could serve as an effective initial treatment for Type 1 decompression sickness, potentially reducing the need for more complex hyperbaric oxygen therapy. This could offer a simpler, more accessible treatment option for Canadian patients experiencing similar altitude-induced decompression sickness.
Canadian Relevance
This study has no direct Canadian connection as it reports on the U.S. Air Force experience.
Study Limitations
The study focuses specifically on Type 1 altitude chamber decompression sickness within a military context, which may limit its generalizability to other forms of DCS or civilian populations.